In the CD8+TCRαβ subtype, patients with PRCA exhibited significantly lower VAFs for STAT3 mutations than those without PRCA (2.3% vs. 18.9%, p = 0.042). The gene discussed is CD8A; the disease is pure red-cell aplasia.